Sun Pharmaceutical Industries revenue and financials

SUNPHARMA · NSE · INR

Compare Sun Pharmaceutical Industries
₹1,880.00Change from previous close: −0.27%Absolute change: −₹5.00

Close · November 13, 2026

In the fiscal year ended March 2026, Sun Pharmaceutical Industries reported revenue of ₹584.62B (+11.19% year over year). Net income was ₹114.79B, a net margin of 19.6%.

Annual revenue · 2026: ₹584.62B
  1. ₹313.08B2017
  2. ₹264.16B2018
  3. ₹290.66B2019
  4. ₹328.38B2020
  5. ₹334.98B2021
  6. ₹386.54B2022
  7. ₹438.86B2023
  8. ₹484.97B2024
  9. ₹525.78B2025
  10. ₹584.62B2026

Fiscal year ending in March. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+11.19%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+5.04%
FY to Mar 2026 vs FY to Mar 2025
Net margin
19.6%
FY to Mar 2025: 20.8%

How Sun Pharmaceutical Industries is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of INR; per-share values in INR; shares in millions.

Income statement · Annual
ItemFY to Mar 2026FY to Mar 2025FY to Mar 2024FY to Mar 2023FY to Mar 2022FY to Mar 2021FY to Mar 2020FY to Mar 2019FY to Mar 2018FY to Mar 2017
Total revenue584,620525,784484,969438,857386,545334,981328,375290,659264,155313,081
Cost of revenue124,786115,585114,422113,187108,76192,18596,79683,83977,77182,701
Gross profit459,834410,200370,547325,670277,784242,796231,579206,820186,385230,380
Selling, general and administrative115,183100,50995,02583,54973,54469,04263,98661,02754,81450,285
Operating income136,116126,055105,20293,05881,56064,27649,47847,37340,90085,720
EBIT136,116126,055105,20293,05881,56064,27649,47847,37340,90085,720
EBITDA163,135149,679128,760116,513101,53683,45168,56764,60255,67998,130
Interest expense3,3892,3142,3851,7201,2741,4143,0275,5064,9103,560
Pre-tax income150,630137,368110,49593,60544,64827,87049,94838,08734,53590,578
Income tax35,54427,72014,3958,47610,7555,1478,2286,0099,11012,116
Net income114,794109,29095,76484,73632,72729,03837,64926,65420,95769,644
Net income to common shareholders114,794109,29095,76484,73632,72729,03837,64926,65420,95769,644
Basic EPS47.8445.5539.9135.3213.6412.1015.6911.118.7328.98
Diluted EPS47.8045.5539.9035.3013.6012.1015.6911.108.7028.98
Average shares (basic)2,3992,3992,3992,3992,3992,3992,3992,3992,3992,403
Average shares (diluted)2,3992,3992,3992,3992,3992,3992,3992,3992,3992,404
Dividend per share16.0016.0013.5011.5010.007.504.002.752.003.50

Companies in the group: same industry, similar size